News
-
NewsGuidelines in Practice readership survey reveals the obstacles facing general practice
Guidelines in Practice readers shared their views on workforce, workload, primary care network development, and the future of primary care
-
News
MHRA makes intravaginal oestrogen medication available without a prescription
Gina 10 mcg tablets (estradiol hemihydrate) have been reclassified from a prescription-only medicine to a pharmacy medicine following a safety review, independent advice, and a public consultation
-
News
RCGP Conference 2022: how can we implement continuity of care in general practice?
Implementing continuity of care in general practice was a key theme at this year’s RCGP annual conference, which took place on 29 June–1 July
-
News
BMS, RCOG, and SfE publish joint position statement on menopause care
The statement focuses on considerations for hormone replacement therapy, with evidence and recommendations on the benefit/risk profile of different options
-
News
Consensus statement on monkeypox published
As cases rise, the UK’s public health agencies have published a consensus statement about preventing and treating monkeypox
-
News
World No Tobacco Day 2022—poisoning our planet
Taking place on 31 May, the focus of World No Tobacco Day this year is on the environmental impact of the tobacco industry
-
News
New guidance published on eating-disorder-related medical emergencies
New RCP guidance covers the recognition and management of medical emergencies in eating disorders, as hospitalisations rise significantly
-
News
10-year plan to tackle dementia announced
A new 10-year plan to tackle dementia and boost neurodegenerative disease research will be published later in the year
-
News
Robotic surgery improves patient recovery times and is safer, finds new study
A recent clinical trial revealed faster recovery times for patients when bladder cancer removal and reconstruction was done with robot-assisted surgery
-
News
NICE recommends combination drug for women with uterine fibroids
Approximately 4500 women with uterine fibroids will be eligible to receive the drug
-
News
NHS staffing should pre-empt the changing medical needs of the UK
NHS staffing and training need to be more ‘fluid’ in response to the health needs of the nation, said a speaker at a meeting of the Health and Social Care Committee on 11 May
-
News
GPs only refer one in 33 people eligible for weight-management programmes
Eligible young White men are the least likely to be referred for weight-management programmes, researchers have found
-
News
Fourth mRNA vaccine dose shown to give ‘substantial’ immunity boost
A new study from the COV-BOOST trial has found that a fourth dose of a COVID-19 vaccine provides a substantial boost to both antibody and cellular immunity
-
News
Mental Health Awareness Week 2022: loneliness
Taking place from 9 to 15 May, the focus this year is on raising awareness of the impact of loneliness on our mental health and the practical steps we can take to address it
-
News
Patient-reported outcomes ‘must be more inclusive to avoid health inequalities’
Patient-reported outcomes need to be collected from all sections of the population to prevent inequalities in healthcare, researchers say
-
News
WHO publishes a global report on infection prevention and control
The report gives a situation analysis of IPC programmes across the world, including data from recent World Health Organization research
-
News
NHS England and NHS Improvement asks staff considering retirement to stay on
A letter to hospital trusts urges staff across the workforce considering retirement to stay and assist efforts to clear the backlog of long-waiting patients
-
News
Life-saving COVID-19 treatment rolled out by NHS
A life-saving drug, typically used to treat arthritis, is now available to treat hospitalised COVID-19 patients
-
News
Severe COVID-19 can cause lasting cognitive and mental health problems
A new study has reported that cognitive impairment from severe COVID-19 is equivalent to 20 years of ageing
-
News
Researchers find treatment for early stage Dupuytren’s disease
A phase-2b trial has shown the effectiveness of an anti-tumour necrosis factor drug for treating the disease at an early stage
